Biosynthesis of iboga alkaloids

Tabernanthe iboga (iboga) is the source of voacangine, which is widely used as a semi-synthetic starting material for the anti-addiction agent ibogaine. Despite extensive investigation of voacangine biosynthesis, production of this compound cannot be reconstituted in a heterologous host, suggesting that one or more enzymes required for biosynthesis are missing. Additionally, T. iboga produces ibophyllidine, a pyrroloindole alkaloid that utilizes the same upstream precursor as voacangine, but is a member of a structurally distinct alkaloid class. Here we use bulk and single cell gene expression from leaf and root tissue to identify the unknown enzymes from these two pathways. We identify two additional enzymes that enable biosynthesis of voacangine in a heterologous host. The missing enzymes includes a pathogenesis-related (PR)10 family protein that likely catalyzes cyclization of a transient intermediate. Careful analysis of gene expression profiles in leaf and root also enabled the discovery of four additional enzymes that convert an upstream intermediate to ibophyllidine. This work reveals the chemical logic that generates two distinct alkaloid scaffolds in this important medicinal plant.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-11-21
DOI
https://doi.org/10.1038/s41467-026-79750-9
Primary Topic
Plant biochemistry and biosynthesis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Biosynthesis of iboga alkaloids

Gyumin Kang, Sarah Ellen O'Connor, Mohamed Omar Kamileen, Maritta Kunert et al.
1 links
Nature Communications
Plant biochemistry and biosynthesis
article

Biosynthesis of iboga alkaloids

Gyumin Kang, Sarah Ellen O'Connor, Mohamed Omar Kamileen, Maritta Kunert, Yoko Nakamura, C. Robin Buell, Lorenzo Caputi, John P. Hamilton, Sarah Heinicke, Moonyoung Kang, Bruno Hüettel, Jens Wurlitzer
article en

Abstract

Tabernanthe iboga (iboga) is the source of voacangine, which is widely used as a semi-synthetic starting material for the anti-addiction agent ibogaine. Despite extensive investigation of voacangine biosynthesis, production of this compound cannot be reconstituted in a heterologous host, suggesting that one or more enzymes required for biosynthesis are missing. Additionally, T. iboga produces ibophyllidine, a pyrroloindole alkaloid that utilizes the same upstream precursor as voacangine, but is a member of a structurally distinct alkaloid class. Here we use bulk and single cell gene expression from leaf and root tissue to identify the unknown enzymes from these two pathways. We identify two additional enzymes that enable biosynthesis of voacangine in a heterologous host. The missing enzymes includes a pathogenesis-related (PR)10 family protein that likely catalyzes cyclization of a transient intermediate. Careful analysis of gene expression profiles in leaf and root also enabled the discovery of four additional enzymes that convert an upstream intermediate to ibophyllidine. This work reveals the chemical logic that generates two distinct alkaloid scaffolds in this important medicinal plant.

Nature CommunicationsVol. 17(1)
University of Georgia (US), Max Planck Institute for Chemical Ecology (DE), Max Planck Institute for Plant Breeding Research (DE)
University of Georgia, Georgia Research Alliance, National Research Foundation of Korea, Max-Planck-Gesellschaft
Plant biochemistry and biosynthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon